Trading Standards Partnership Advisory Meeting
This ACI members event will be hosted by Senior Trading Standards Officers. The webinar will provide an opportunity for ACI members to get to know and ask questions to Trading Standards. Date: Friday 26 March 2021 Time: 4pm GMT This event is exclusively for ACI members.
[NutraIngredients] CBD experts recommend THC limit for finished products
CBD industry experts have put together a detailed safety review of THC recommending clear policy recommendations to cut market confusion reports NutraIngredients
[Canex] ACI and CMC Recommend 0.03% THC Limit for CBD Products
Canex cover news of the release of our detailed safety review report on THC.
Research Paper: ACI and CMC Recommend Home Office Clarifies THC Limits for CBD Products
Experts from the Association for the Cannabinoid Industry (ACI) and Centre for Medicinal Cannabis (CMC) have put together a detailed safety review paper of THC – Health Guidance Levels for THC in CBD products: Safety Assessment & Regulatory Recommendations. The paper recommends further research and makes policy recommendations.
[Analytical Cannabis] The UK Needs A 0.03% THC Limit for CBD Products, Says Industry Group
As outlined in ACI’s report “Health Guidance Levels for THC in CBD products,” the industry group recommend that the UK Home Office enacts a cap of 0.021 mg/kg of THC (and other cannabinol derivatives) per day. This limit would be equivalent to permitting 0.03 percent THC per the recommended 70 mg daily intake of CBD.
[NutraIngredients] Treehouse Biotech submits Novel Foods Application to UK authorities
ACI member Treehouse Biotech has submitted a Novel Foods application to UK authorities for its Cannabidiol (CBD)-based ingredients in a move that signals the US firm’s intent to capture a slice of the UK’s burgeoning CBD market.
ACI Forms Exclusive Partnership with PR Agency Ingredient Communications to Offer B2B Comms Support for Members
Today ACI announced an exclusive partnership with the UK’s leading PR agency specialising in B2B communications in the food and nutrition sectors, Ingredient Communications.
[Pharmacy Business Magazine] Industry body welcomes FSA update on CBD products
Pharmacy Business Magazine reports that the FSA updated the criteria for CBD products which can remain on sale from 1 April 2021. Previously, only products which were on sale at the time of the FSA’s announcement (13 February 2020) and were linked to an application which had been validated by 31 March 2021 were to be included.
[Analytical Cannabis] The UK’s Food Standards Agency Updates its CBD Novel Foods Criteria
Last February, the Food Standards Agency (FSA) announced that all CBD businesses operating in England and Wales must have a novel foods application “validated” by March 31, 2021, or risk having their CBD oils, drinks, and treats “taken off the shelves.” Now, with just over two weeks left until the deadline, the FSA has clarified that all applications just have to be “submitted” by March 31, 2021.
[Hemp Grower] CBD Manufacturers Band Together to Sell Products in UK as Deadline Looms
Coverage from the US publication Hemp Grower on the requirement for novel foods applications to sell CBD products in the UK.
